Cargando…
New Interventional Therapies beyond Stenting to Treat ST-Segment Elevation Acute Myocardial Infarction
Myocardial infarction remains the principal cause of death in Europe. In patients with ST-segment-elevation myocardial infarction (STEMI), a promptly revascularization with primary percutaneous intervention (PCI) has transformed prognosis in the last decades. However, despite increasing successful P...
Autores principales: | Vidal-Calés, Pablo, Cepas-Guillén, Pedro L., Brugaletta, Salvatore, Sabaté, Manel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469769/ https://www.ncbi.nlm.nih.gov/pubmed/34564118 http://dx.doi.org/10.3390/jcdd8090100 |
Ejemplares similares
-
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
por: Sabaté, Manel, et al.
Publicado: (2016) -
Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
por: Schur, Nadine, et al.
Publicado: (2018) -
“Goldilocks” Approach to Deferred Stenting in ST‐Segment–Elevation Myocardial Infarction
por: Yong, Celina M., et al.
Publicado: (2022) -
Characteristics and mechanism of reciprocal ST-segment depression in acute ST segment elevation myocardial infarction: Reciprocal ST-segment depression and ST segment elevation myocardial infarction
por: Gao, Qijun, et al.
Publicado: (2022) -
Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
por: Velders, M. A., et al.
Publicado: (2014)